Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds - The ASCO Post
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds The ASCO Post
Hodgkin Lymphoma News
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase - CancerNetwork
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase CancerNetwork
Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better Diagnostics - WCM Newsroom
Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better Diagnostics WCM Newsroom
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - UT MD Anderson
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult UT MD Anderson
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal - Nature
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal Nature
Post-Treatment Fertility in Hodgkin Lymphoma - Hematology Advisor
Post-Treatment Fertility in Hodgkin Lymphoma Hematology Advisor
The guitarist was first diagnosed with Hodgkin lymphoma in 2013. - facebook.com
The guitarist was first diagnosed with Hodgkin lymphoma in 2013. facebook.com
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma - Clemson University Athletics
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma Clemson University Athletics
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - Medical Xpress
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult Medical Xpress
Metachronous EBV-positive classical Hodgkin lymphoma following EBV-positive diffuse large B-cell lymphoma: a case report and literature review - Frontiers
Metachronous EBV-positive classical Hodgkin lymphoma following EBV-positive diffuse large B-cell lymphoma: a case report and literature review Frontiers
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma - CancerNetwork
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma CancerNetwork
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Frontiers
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” Frontiers
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma - CancerNetwork
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma CancerNetwork
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma - CancerNetwork
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma CancerNetwork
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma - CancerNetwork
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma CancerNetwork
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma - Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma Nature
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers
Rock icon says his cancer has returned following transplant: ‘Not slowing down’ - PennLive.com
Rock icon says his cancer has returned following transplant: ‘Not slowing down’ PennLive.com
Primary pancreatic non-Hodgkin lymphoma (with... : Endoscopic Ultrasound - Ovid
Primary pancreatic non-Hodgkin lymphoma (with... : Endoscopic Ultrasound Ovid
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? - Clinical Trials Arena
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? Clinical Trials Arena
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition - Inside Precision Medicine
Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition Inside Precision Medicine
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma - OncLive
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma OncLive
Richter transformation to classical Hodgkin lymphoma following recurrent disseminated histoplasmosis in chronic lymphocytic leukemia: a Case Report - Frontiers
Richter transformation to classical Hodgkin lymphoma following recurrent disseminated histoplasmosis in chronic lymphocytic leukemia: a Case Report Frontiers
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma - UT MD Anderson
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma UT MD Anderson
Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma - CancerNetwork
Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma CancerNetwork
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life - UT MD Anderson
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life UT MD Anderson
Study reveals promising new therapy for non-Hodgkin lymphoma - Medical Xpress
Study reveals promising new therapy for non-Hodgkin lymphoma Medical Xpress
Favezelimab Combo Boosts PFS vs Chemo in PD-1–Refractory Hodgkin Lymphoma - CancerNetwork
Favezelimab Combo Boosts PFS vs Chemo in PD-1–Refractory Hodgkin Lymphoma CancerNetwork
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study - Nature
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study Nature
Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story - Roswell Park Comprehensive Cancer Center
Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story Roswell Park Comprehensive Cancer Center
7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore - Hartford HealthCare
7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore Hartford HealthCare
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma - The ASCO Post
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma The ASCO Post
FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma - CancerNetwork
FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma CancerNetwork
Clinical features, outcomes, and prognostic factors of lymphocyte-depleted classical Hodgkin lymphoma: a population-based SEER analysis - Nature
Clinical features, outcomes, and prognostic factors of lymphocyte-depleted classical Hodgkin lymphoma: a population-based SEER analysis Nature
Coexistence of Mycosis Fungoides and Hodgkin Lymphoma in a Pediatric Patient: A Report of a Rare Case - Cureus
Coexistence of Mycosis Fungoides and Hodgkin Lymphoma in a Pediatric Patient: A Report of a Rare Case Cureus